Protective and immunomodulatory effect of flos Lonicerae japonicae by augmenting IL-10 expression in a murine model of acute lung inflammation

J Ethnopharmacol. 2015 Jun 20:168:108-15. doi: 10.1016/j.jep.2015.03.012. Epub 2015 Mar 24.

Abstract

Ethnopharmacological relevance: Lonicerae japonicae has shown antibacterial, anti-inflammatory, antipyretic, antioxidant, antiviral, and protective effects in animal models of chronic obstructive pulmonary disease.

Aim of the study: To investigate the effects of Flos L. japonicae (FLJ), a traditional Chinese medicinal herb, on acute lung inflammation induced by lipopolysaccharide (LPS), in vivo, using a murine model.

Materials and methods: Thirty 6-week-old female BALB/c mice were challenged with intratracheal LPS before treatment with FLJ or vehicle. FLJ was examined for its capacity to influence an LPS-induced increase in IL-10 and decrease in TNF-α, IL-1β and IL-6 as measured in murine bronchoalveolar lavage (BALF).

Results: FLJ increased nuclear Sp1 binding activity thereby enhancing the expression of IL-10 and decreased nuclear NF-κB binding activities thereby inhibiting the expression of TNF-α, IL-1β and IL-6 in the lung. The up-regulation of Sp1 activity by FLJ was through incremental phosphorylation of ERK. By contrast, the down-regulation of NF-κB activity by FLJ was through suppression of the phosphorylation of IκB, p38, and JNK.

Conclusions: We demonstrated FLJ has protective activity against LPS-induced lung inflammatory cytokine release. Anti-inflammatory cytokine, IL-10, may prove beneficial in the treatment of endotoxin-associated lung inflammation.

Keywords: Flos Lonicerae japonicae; Interleukin-10; Interleukin-6; Lung inflammatorn; NF-κB; STAT-3; Sp1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / metabolism
  • Acute Lung Injury / pathology
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / cytology
  • Cell Count
  • Cytokines / genetics
  • Cytokines / metabolism
  • Disease Models, Animal
  • Female
  • I-kappa B Proteins / metabolism
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Lipopolysaccharides
  • Lonicera*
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Mice, Inbred BALB C
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Nitrates / metabolism
  • Nitrites / metabolism
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Pneumonia / drug therapy*
  • Pneumonia / metabolism
  • Pneumonia / pathology
  • RNA, Messenger / metabolism
  • Sp1 Transcription Factor / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • I-kappa B Proteins
  • Immunologic Factors
  • Lipopolysaccharides
  • NF-kappa B
  • Nitrates
  • Nitrites
  • Plant Extracts
  • RNA, Messenger
  • Sp1 Transcription Factor
  • Mitogen-Activated Protein Kinases